AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Evogene Q2 2025 Earnings Preview: EPS and Revenue Estimates Ahead of August 19th Release
ByAinvest
Monday, Aug 18, 2025 12:41 pm ET1min read
Evogene is set to announce Q2 2025 earnings on August 19th. The consensus EPS estimate is -$0.63, a 40.6% YoY increase, while the revenue estimate is $0.93M, a 2.2% YoY increase. Over the past two years, Evogene has reported an average EPS of -$0.36 and an average revenue of $0.92M.
Evogene (NASDAQ:EVGN) is scheduled to announce its Q2 2025 earnings results on Tuesday, August 19, before the market opens. The consensus earnings per share (EPS) estimate stands at -$0.63, representing a 40.6% year-over-year (YoY) increase, while the consensus revenue estimate is $0.93 million, a 2.2% YoY increase [1].Over the past two years, Evogene has shown a consistent trend of beating EPS estimates, with a success rate of 75% and a revenue estimate beat rate of 63% [1]. In Q1 2025, the company reported an EPS of -$0.38, which exceeded analysts' consensus estimates by $0.12, while revenue was $2.44 million, below the consensus estimate of $4.42 million [2].
The upcoming earnings announcement is expected to provide insights into Evogene's financial performance for the second quarter of 2025. Investors will be closely watching for any updates on the company's strategic initiatives, financial health, and future growth prospects. The conference call is scheduled for 9:00 AM ET on August 19, with transcripts and audio expected to be available shortly thereafter [2].
References:
[1] https://seekingalpha.com/news/4486643-evogene-q2-2025-earnings-preview
[2] https://www.marketbeat.com/stocks/NASDAQ/EVGN/earnings/
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet